180 related articles for article (PubMed ID: 36822077)
21. Clonal hematopoiesis and associated diseases: A review of recent findings.
Asada S; Kitamura T
Cancer Sci; 2021 Oct; 112(10):3962-3971. PubMed ID: 34328684
[TBL] [Abstract][Full Text] [Related]
22. [Clonal hematopoiesis: a risk factor for leukemia and cardiovascular disease?].
van Zeventer IA; Buisman SC; de Graaf AO; de Haan G; Jansen JH; Huls G
Ned Tijdschr Geneeskd; 2020 Nov; 164():. PubMed ID: 33331716
[TBL] [Abstract][Full Text] [Related]
23. Dynamics of mutant BCR-ABL-positive clones after cessation of tyrosine kinase inhibitor therapy.
Hanfstein B; Müller MC; Kreil S; Ernst T; Schenk T; Lorentz C; Schwindel U; Leitner A; Hehlmann R; Hochhaus A
Haematologica; 2011 Mar; 96(3):360-6. PubMed ID: 21134983
[TBL] [Abstract][Full Text] [Related]
24. Forced expression of Wnt antagonists sFRP1 and WIF1 sensitizes chronic myeloid leukemia cells to tyrosine kinase inhibitors.
Pehlivan M; Caliskan C; Yuce Z; Sercan HO
Tumour Biol; 2017 May; 39(5):1010428317701654. PubMed ID: 28468589
[TBL] [Abstract][Full Text] [Related]
25. Clonal hematopoiesis and cardiovascular disease: deciphering interconnections.
Stein A; Metzeler K; Kubasch AS; Rommel KP; Desch S; Buettner P; Rosolowski M; Cross M; Platzbecker U; Thiele H
Basic Res Cardiol; 2022 Nov; 117(1):55. PubMed ID: 36355225
[TBL] [Abstract][Full Text] [Related]
26. Clonal Hematopoiesis and risk of Acute Myeloid Leukemia.
Desai P; Hassane D; Roboz GJ
Best Pract Res Clin Haematol; 2019 Jun; 32(2):177-185. PubMed ID: 31203999
[TBL] [Abstract][Full Text] [Related]
27. [Clonal hematopoiesis: causes and clinical implications].
Burchert A
Z Gerontol Geriatr; 2023 Feb; 56(1):65-72. PubMed ID: 36662242
[TBL] [Abstract][Full Text] [Related]
28. BCR-ABL1 tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia.
Cuellar S; Vozniak M; Rhodes J; Forcello N; Olszta D
J Oncol Pharm Pract; 2018 Sep; 24(6):433-452. PubMed ID: 28580869
[TBL] [Abstract][Full Text] [Related]
29. Clonal hematopoiesis and cardiovascular diseases: role of JAK2V617F.
Misaka T; Kimishima Y; Yokokawa T; Ikeda K; Takeishi Y
J Cardiol; 2023 Jan; 81(1):3-9. PubMed ID: 35165011
[TBL] [Abstract][Full Text] [Related]
30. The INK4-ARF (CDKN2A/B) locus in hematopoiesis and BCR-ABL-induced leukemias.
Williams RT; Sherr CJ
Cold Spring Harb Symp Quant Biol; 2008; 73():461-7. PubMed ID: 19028987
[TBL] [Abstract][Full Text] [Related]
31. Clinical impact of clonal hematopoiesis in acute myeloid leukemia patients receiving allogeneic transplantation.
Grimm J; Bill M; Jentzsch M; Beinicke S; Häntschel J; Goldmann K; Schulz J; Cross M; Franke GN; Behre G; Vucinic V; Pönisch W; Lange T; Niederwieser D; Schwind S
Bone Marrow Transplant; 2019 Aug; 54(8):1189-1197. PubMed ID: 30504903
[TBL] [Abstract][Full Text] [Related]
32. Clonal Hematopoiesis and therapy related MDS/AML.
Desai P; Roboz GJ
Best Pract Res Clin Haematol; 2019 Mar; 32(1):13-23. PubMed ID: 30927970
[TBL] [Abstract][Full Text] [Related]
33. BCR-ABL kinase domain mutations, including 2 novel mutations in imatinib resistant Malaysian chronic myeloid leukemia patients-Frequency and clinical outcome.
Elias MH; Baba AA; Azlan H; Rosline H; Sim GA; Padmini M; Fadilah SA; Ankathil R
Leuk Res; 2014 Apr; 38(4):454-9. PubMed ID: 24456693
[TBL] [Abstract][Full Text] [Related]
34. [Tyrosine kinase inhibitor-associated cardiovascular adverse events in chronic myeloid leukemia].
Miyazaki S
Rinsho Ketsueki; 2021; 62(8):1024-1028. PubMed ID: 34497188
[TBL] [Abstract][Full Text] [Related]
35. Several types of mutations of the Abl gene can be found in chronic myeloid leukemia patients resistant to STI571, and they can pre-exist to the onset of treatment.
Roche-Lestienne C; Soenen-Cornu V; Grardel-Duflos N; Laï JL; Philippe N; Facon T; Fenaux P; Preudhomme C
Blood; 2002 Aug; 100(3):1014-8. PubMed ID: 12130516
[TBL] [Abstract][Full Text] [Related]
36. [Clonal hematopoiesis of undetermined potential (CHIP) and clonal cytopenia of unknown significance (CCUS) - Consequences for the clinic].
Ziemann F; Metzeler KH
Dtsch Med Wochenschr; 2023 Apr; 148(8):441-450. PubMed ID: 36990116
[TBL] [Abstract][Full Text] [Related]
37. Therapy-selected clonal hematopoiesis and its role in myeloid neoplasms.
Jahn J; Diamond B; Hsu J; Montoya S; Totiger TM; Landgren O; Maura F; Taylor J
Leuk Res; 2023 Mar; 126():107020. PubMed ID: 36696829
[TBL] [Abstract][Full Text] [Related]
38. c-abl function in normal and chronic myelogenous leukemia hematopoiesis: in vitro studies with antisense oligomers.
Rosti V; Bergamaschi G; Ponchio L; Cazzola M
Leukemia; 1992 Jan; 6(1):1-7. PubMed ID: 1736009
[TBL] [Abstract][Full Text] [Related]
39. Incidence and outcome of BCR-ABL mutated chronic myeloid leukemia patients who failed to tyrosine kinase inhibitors.
Etienne G; Dulucq S; Huguet F; Schmitt A; Lascaux A; Hayette S; Fort MP; Sujobert P; Bijou F; Morisset S; Tavitian S; Bidet A; Turcq B; Robbesyn F; Chollet C; Belloc F; Durrieu F; Mahon FX; Nicolini FE
Cancer Med; 2019 Sep; 8(11):5173-5182. PubMed ID: 31350815
[TBL] [Abstract][Full Text] [Related]
40. Exploring the Associations Between Clonal Hematopoiesis of Indeterminate Potential, Myeloid Malignancy, and Atherosclerosis.
Menendez-Gonzalez JB; Rodrigues NP
Methods Mol Biol; 2022; 2419():73-88. PubMed ID: 35237959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]